Evidence map›Paper›PMID 30470548›Full record

ReviewTrends in biotechnology2019

Zinc-Based Biomaterials for Regeneration and Therapy.

Yingchao Su, Irsalan Cockerill, Yadong Wang, Yi-Xian Qin, Lingqian Chang, Yufeng Zheng, Donghui Zhu

Abstract readReview
In one paragraph

Review in Trends in biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 1 synthesis or guideline pooled it, 398 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Ion-Driven Regulation of CaAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Construction of ZnGels (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. International journal of molecular sciences · 2026
    Article
  18. Article
  19. Review
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yingchao SuDepartment of Biomedical Engineering, University of North Texas, Denton, TX, USA.
Irsalan CockerillDepartment of Biomedical Engineering, University of North Texas, Denton, TX, USA.
Yadong WangNancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Yi-Xian QinDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, USA.
Lingqian ChangDepartment of Biomedical Engineering, University of North Texas, Denton, TX, USA. Electronic address: Lingqian.chang@unt.edu.
Yufeng ZhengDepartment of Materials Science and Engineering, College of Engineering, Peking University, Beijing, China. Electronic address: yfzheng@pku.edu.cn.
Donghui ZhuDepartment of Biomedical Engineering, University of North Texas, Denton, TX, USA. Electronic address: Donghui.Zhu@unt.edu.
University of North Texas · USCornell University · USPeking University · CNStony Brook University · US

Funding

Novel surface-modified bioresorbable zinc-based stent materialsR01HL140562 · NHLBI · UNIVERSITY OF NORTH TEXAS · PI Ke Cheng, Donghui Zhu · 2018 to 2026
$4.3M
NHLBI NIH HHS R01 HL140562
6 · The paper itself

Abstract

Zinc has been described as the 'calcium of the twenty-first century'. Zinc-based degradable biomaterials have recently emerged thanks to their intrinsic physiological relevance, biocompatibility, biodegradability, and pro-regeneration properties. Zinc-based biomaterials mainly include: metallic zinc alloys, zinc ceramic nanomaterials, and zinc metal-organic frameworks (MOFs). Metallic zinc implants degrade at a desirable rate, matching the healing pace of local tissues, and stimulating remodeling and formation of new tissues. Zinc ceramic nanomaterials are also beneficial for tissue engineering and therapy thanks to their nanostructures and antibacterial properties. MOFs have large surface areas and are easily functionalized, making them ideal for drug delivery and cancer therapy. This review highlights recent developments in zinc-based biomaterials, discusses obstacles to overcome, and pinpoints directions for future research.

Indexed as

Biocompatible MaterialsRegenerationRegenerative MedicineTrace ElementsZincBiocompatible MaterialsTrace ElementsZincbiodegradablebiometalbioresorbablenanomaterialstissue engineeringzinc

Identifiers

PMID30470548
PMCPMC6421092
OpenAlexW2900857934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.